192 related articles for article (PubMed ID: 1586061)
41. [Application of recombinant 38000 protein antigen of Mycobacterium tuberculosis in screening Mycobacterium tuberculosis infection].
He XY; Zhuang YH; Zhang XG
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Aug; 32(8):581-4. PubMed ID: 19958675
[TBL] [Abstract][Full Text] [Related]
42. Clinical application of the Mycobacterium tuberculosis direct test: case report, literature review, and proposed clinical algorithm.
Gladwin MT; Plorde JJ; Martin TR
Chest; 1998 Jul; 114(1):317-23. PubMed ID: 9674487
[TBL] [Abstract][Full Text] [Related]
43. Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners.
Corbett EL; Blumberg L; Churchyard GJ; Moloi N; Mallory K; Clayton T; Williams BG; Chaisson RE; Hayes RJ; De Cock KM
Am J Respir Crit Care Med; 1999 Jul; 160(1):15-21. PubMed ID: 10390374
[TBL] [Abstract][Full Text] [Related]
44. [Tuberculin sensitivity to purified protein derivatives (PPD) from M. intracellulare (PPD-B), M. kansasii (PPD-Y), M. fortuitum (PPD-Y) and M. tuberculosis (PPDs) among healthy volunteers].
Shigeto E; Tasaka H
Kekkaku; 1993 Apr; 68(4):283-91. PubMed ID: 8497118
[TBL] [Abstract][Full Text] [Related]
45. Selection of skin test antigens to evaluate PPD anergy.
Wright PW; Crutcher JE; Holiday DB
J Fam Pract; 1995 Jul; 41(1):59-64. PubMed ID: 7798066
[TBL] [Abstract][Full Text] [Related]
46. Clinical evaluation of the QuantiFERON-TB Gold test in patients with non-tuberculous mycobacterial disease.
Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Okimoto N; Matsushima T; Kageoka T; Oka M
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1422-6. PubMed ID: 19861017
[TBL] [Abstract][Full Text] [Related]
47. [Antigenic response against PPD and antigen 60 in tubercular patients: single antigen versus the combined test].
Máttar S; Broquetas JM; Gea J; Aran X; el-Banna N; Sauleda J; Torres JM
Enferm Infecc Microbiol Clin; 1992 May; 10(5):272-6. PubMed ID: 1390996
[TBL] [Abstract][Full Text] [Related]
48. Pre-sensitization with tuberculosis and non-tuberculosis mycobacteria and its impact on TB incidence in different age groups: Chengalpattu BCG trial revisited.
Mohan P; Basilea W; Radhamani MP; Rajendran K; Soumya S; Datta M
Tuberculosis (Edinb); 2023 Mar; 139():102322. PubMed ID: 36780825
[TBL] [Abstract][Full Text] [Related]
49. Impact of immigration on tuberculosis infection among Canadian-born schoolchildren and young adults in Montreal.
Menzies D; Chan CH; Vissandjée B
Am J Respir Crit Care Med; 1997 Dec; 156(6):1915-21. PubMed ID: 9412575
[TBL] [Abstract][Full Text] [Related]
50. Consequence of prior exposure to environmental mycobacteria on BCG vaccination and diagnosis of tuberculosis infection.
Thom M; Howard C; Villarreal-Ramos B; Mead E; Vordermeier M; Hope J
Tuberculosis (Edinb); 2008 Jul; 88(4):324-34. PubMed ID: 18329343
[TBL] [Abstract][Full Text] [Related]
51. Cellular and humoral immunity to purified protein derivative (PPD) in PPD skin reactive and nonreactive patients with pulmonary tuberculosis: comparative analysis of antigen-specific lymphocyte proliferation and IgG antibodies.
Boras Z; Juretić A; Rudolf M; Uzarević B; Trescec A
Croat Med J; 2002 Jun; 43(3):301-5. PubMed ID: 12035136
[TBL] [Abstract][Full Text] [Related]
52. Atypical mycobacteria causing pulmonary disease: rapid diagnosis using skin test profiles.
Vandiviere HM; Dillon M; Melvin IG
South Med J; 1987 Jan; 80(1):5-9. PubMed ID: 3798188
[TBL] [Abstract][Full Text] [Related]
53. Bovine tuberculosis: effect of the tuberculin skin test on in vitro interferon gamma responses.
Schiller I; Vordermeier HM; Waters WR; Whelan AO; Coad M; Gormley E; Buddle BM; Palmer M; Thacker T; McNair J; Welsh M; Hewinson RG; Oesch B
Vet Immunol Immunopathol; 2010 Jul; 136(1-2):1-11. PubMed ID: 20219253
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of bovine cutaneous delayed-type hypersensitivity (DTH) to various test antigens and a mitogen using several adjuvants.
Hernández A; Yager JA; Wilkie BN; Leslie KE; Mallard BA
Vet Immunol Immunopathol; 2005 Mar; 104(1-2):45-58. PubMed ID: 15661330
[TBL] [Abstract][Full Text] [Related]
55. [Clinical features of the lung diseases due to Mycobacterium avium and M. intracellulare].
Toyoda T; Aoyagi T; Saito H
Kekkaku; 1993 Jan; 68(1):63-9. PubMed ID: 8437427
[TBL] [Abstract][Full Text] [Related]
56. Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact.
Arend SM; Engelhard AC; Groot G; de Boer K; Andersen P; Ottenhoff TH; van Dissel JT
Clin Diagn Lab Immunol; 2001 Nov; 8(6):1089-96. PubMed ID: 11687445
[TBL] [Abstract][Full Text] [Related]
57. Evidence of previous infection with Mycobacterium avium-Mycobacterium intracellulare complex among healthy subjects: an international study of dominant mycobacterial skin test reactions.
von Reyn CF; Barber TW; Arbeit RD; Sox CH; O'Connor GT; Brindle RJ; Gilks CF; Hakkarainen K; Ranki A; Bartholomew C
J Infect Dis; 1993 Dec; 168(6):1553-8. PubMed ID: 8245545
[TBL] [Abstract][Full Text] [Related]
58. Tuberculin dual testing in Panama.
Larrabee WF; Talarera R
Tubercle; 1980 Dec; 61(4):239-43. PubMed ID: 6792757
[TBL] [Abstract][Full Text] [Related]
59. Profiling serum antibodies to Mycobacterium tuberculosis proteins in rhesus monkeys with nontuberculous Mycobacteria.
Min F; Pan J; Wu R; Chen M; Kuang H; Zhao W
Exp Anim; 2016; 65(1):11-6. PubMed ID: 26437786
[TBL] [Abstract][Full Text] [Related]
60. [Non-tuberculous mycobacteriosis. What has been coming out].
Kajiki A
Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
